1. Home
  2. YOUL vs TCRX Comparison

YOUL vs TCRX Comparison

Compare YOUL & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Youlife Group Inc. American Depositary Shares

YOUL

Youlife Group Inc. American Depositary Shares

N/A

Current Price

$0.50

Market Cap

47.2M

Sector

Real Estate

ML Signal

N/A

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

HOLD

Current Price

$0.79

Market Cap

49.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YOUL
TCRX
Founded
2020
2018
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.2M
49.4M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
YOUL
TCRX
Price
$0.50
$0.79
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.00
AVG Volume (30 Days)
175.7K
391.2K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
12.28
EPS
N/A
N/A
Revenue
N/A
$10,325,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$19.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
266.65
52 Week Low
$0.29
$0.72
52 Week High
$4.40
$2.57

Technical Indicators

Market Signals
Indicator
YOUL
TCRX
Relative Strength Index (RSI) 51.03 N/A
Support Level $0.49 N/A
Resistance Level $0.54 N/A
Average True Range (ATR) 0.06 0.00
MACD 0.01 0.00
Stochastic Oscillator 77.22 0.00

Price Performance

Historical Comparison
YOUL
TCRX

About YOUL Youlife Group Inc. American Depositary Shares

Youlife Group Inc is a blue-collar lifetime service platform in China, dedicated to serving the needs throughout the entire life cycle of the blue-collar talent. It provides blue-collar lifetime services to students, blue-collar talent, and corporate customers. Its segments are the vocational education segment, which engages in the provision of vocational education entrusted management services, self-operated vocational school services, and Others; the HR recruitment segment engages in the provision of HR recruitment services regarding blue-collar talent to customers; the employee management segment engages in the provision of labor outsourcing services, labor dispatch services and others; and the market service segment engages in the provision of value-added services.

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Share on Social Networks: